1. Home
  2. Analysis
  3. Magnesium-gluconate
  4. Prograf

Magnesium gluconate and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium gluconate (magnesium) and Prograf (tacrolimus). Common drug interactions include anaemia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium gluconate and Prograf. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium gluconate?

Magnesium gluconate has active ingredients of magnesium. eHealthMe is studying from 2,286 Magnesium gluconate users. Check the latest studies of Magnesium gluconate.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

On Jul, 06, 2026

20 people who take Magnesium gluconate and Prograf together, and have interactions are studied.

Magnesium gluconate and Prograf drug interactions.

What are the common drug interactions of Magnesium Gluconate and Prograf, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Blood creatinine increased
  3. Drug ineffective
  4. Dyspnoea (difficult or laboured respiration)
  5. Amylase increased
  6. Blood cholesterol increased
  7. Blood sodium decreased
  8. Blood triglycerides increased
  9. Blood uric acid increased
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

male:

  1. Diarrhoea
  2. B-cell lymphoma (blood cancer affecting b cells)
  3. Ruptured cerebral aneurysm (bleeding from brain)
  4. Acute promyelocytic leukaemia (cancer of the blood and bone marrow)
  5. Alanine aminotransferase increased
  6. Aspartate aminotransferase increased
  7. Blood alkaline phosphatase increased
  8. Blood creatinine increased
  9. Chronic kidney disease
  10. Dyspepsia (indigestion)

What are the common drug interactions of Magnesium Gluconate and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)

10-19:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Blood creatinine increased
  5. Blood urea increased
  6. Encephalitis (inflammation of the brain)
  7. Gamma-glutamyltransferase increased
  8. Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)

20-29:

n/a

30-39:

  1. Immunosuppressant drug level increased
  2. Angioedema (rapid swelling of the dermis)
  3. Dyspnoea (difficult or laboured respiration)

40-49:

  1. Acute promyelocytic leukaemia (cancer of the blood and bone marrow)
  2. Renal cell carcinoma stage i (the tumour is 7 centimetres or smaller and is found only in the kidney)

50-59:

  1. Erythema (redness of the skin)
  2. Face oedema (swelling of face)
  3. Localised oedema (fluid retention in a particular part of the body)

60+:

  1. Diarrhoea
  2. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  3. Rectal haemorrhage (bleeding from anus)
  4. Ruptured cerebral aneurysm (bleeding from brain)
  5. Amylase increased
  6. Blood cholesterol increased
  7. Blood sodium decreased
  8. Blood triglycerides increased
  9. Blood uric acid increased
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Pain: 4 people, 20.00%
  2. High Blood Pressure: 3 people, 15.00%
  3. Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 10.00%
  4. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 2 people, 10.00%
  5. Blood Magnesium Decreased: 2 people, 10.00%
  6. Immunodeficiency Disorders: 2 people, 10.00%
  7. Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 10.00%
  8. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 2 people, 10.00%
  9. Blood Count Abnormal: 1 person, 5.00%
  10. Blood Creatinine Increased: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium gluconate and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Magnesium gluconate and Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium gluconate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium gluconate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on magnesium and tacrolimus (the active ingredients of Magnesium gluconate and Prograf, respectively), and Magnesium gluconate and Prograf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.